This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen, F. (1984). Reputation and product quality. RAND Journal of Economics, 15:311–327.
Arrow, K. J. (1963). Uncertainty and the welfare economics of medical care. American Economic Review, 53(5):941–973.
Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17:99–120.
BMBF (1993). Faktenbericht 1992 zum Bundesbericht Forschung. Technical report.
BMBF (1998). Faktenbericht 1997 zum Bundesbericht Forschung. Technical report.
BMBF (2003). Faktenbericht 2002 zum Bundesbericht Forschung. Technical report.
Brealy, R. and Myers, S. (2000). Principles of Corporate Finance. McGraw-Hill: New York.
Bundesministerium für Bildung und Wissenschaft (BMBW) (1971). Erster Ergebnisbericht des ad-hoc-Ausschusses ŞNeue TechnologienŤ, volume 6 of Schriftenreihe Forschungsplanung. Bonn.
Bundesministerium für Wissenschaftliche Forschung (BMWF) (1969). Bundesbericht Forschung 3. Bonn.
Bundesmnisterium für Forschung und Technologie (BMFT) (1972). Bericht über die Japanreise einer Expertenkommission für Biotechnologie. Bonn.
Carpenter, R. and Petersen, B. (2002). Capital market imperfections, high-tech investment, and new equity financing. The Economic Journal, 112:54–72.
Chesbrough, H. (1999). The differing organizational impact of technological change: A comparative theory of national institutional factors, Industrial and Corporate Change, 8:447–485.
Czarnitzki, D. and Fier, A. (2003). Publicly funded R&D collaborations and patent outcome in Germany. Technical report, ZEW Discussion Paper 03-24, Mannheim.
Di Masi, J., Hansen, R., and Grabowski, H. (2003). The price of innovation: New estimates of drug development costs. Journal of Health Economics, 22(2):151–185.
Diamond, D. (1989). Reputation acquisition in debt markets. Journal of Political Economy, 97:828–862.
Dohse, D. (2000). Technology policy and the regions Ű the case of the bioregio contest. Research Policy, 29:1111–1133.
Downs, A. (1957). An Economic Theory of Democracy. New York: Harper & Row Publishers.
Ernst and Young (2004). Biotechnology. source: www.ibef.org, accessed on January 2006.
European Commission (2004). Biowissenschaften und Biotechnologie — Eine Strategie für Europa. In Mitteilung der Kommission an das Europäische Parlament, number 27, pages 7–50.
Fiet, J. (1995). Risk avoidance strategies in venture capital markets. Journal of Management Studies, 32(4):551–574.
Fiet, J. O. (1991). Network reliance by venture capital firms and business angels: An empirical and theoretical test. In Frontiers of Entrepreneurship Research, pages 445–455. Babson College.
Giesecke, S. (2000). The contrasting roles of government in the development of biotechnology industry in the US and Germany. Research Policy, 29:205–223. Greene, W. (2000). Econometric Analysis, volume 4. New York.
Greene, W. (2003). Econometric Analysis, volume 5. New York.
Harding, R. (2003). Why invest in biotechnology, and how? Britain and Germany compared. Technical report, Anglo-German Foundation for the Study of Industrial Society, London.
Harhoff, D. and Stahl, K. (1995). Unternehmens- und beschaeftigungsdynamik in Westdeutsch-land: Zum einfluss von haftungsregeln und eigentuemerstruktur. In Oppenländer, K. H., editor, Industrieoekonomik und Finanzmaerkte, volume 41 of ifo Studien, pages 17–50.
Harhoff, D. and Steil, F. (1997). Die zew-gruendungspanels: Konzeptionelle ueberlegungen und analysepotential. In Harhoff, D., editor, Unternehmensgruendungen — Empirische Analysen fuer die alten und neuen Bundeslaender, volume 7. Baden-Baden.
Herstatt, C., Müller, C., and Fujiwara, T. (2004). Sources of bioentrepreneurship: The cases of Germany and Japan. Journal of Small Business Management, 42(1).
Kirzner, I. (1973). Entrepreneurship and Competition. Chicago: University of Chicago Press.
Klein, B. and Leffler, K. (1981). The role of market forces in assuring contractual performance. Journal of Political Economy, 89:615–641.
Knight, F. (1921). Risk, uncertainty and profit. New York: Houghton Mifflin, 2021:226–228.
Müller, C. and Herstatt, C. (2004). Einflussfaktoren auf die Effizienz von FuE-Kooperationen in der Biotechnologie-Branche — Eine kausalanalytische Untersuchung. Technical Report 20, TU Harburg.
Nelson, R. (1959). The simple economics of basic scientific research. The Journal of Political Economy, 67(3):297–306.
NIST (2004). Measuring ATP Impact: 2004 Report on Economic Progress. Annual Report, Gaithersburg.
OECD (1966). Wages and Labour Mobility. Paris: OECD.
Ollig, W. (2001). Strategiekonzepte für Biotechnologie-Unternehmen: Gründung, Entwicklungsp-fade, Geschäftsmodelle. Deutscher Universitäts-Verlag.
Orsenigo, L. (1989). The Emergence of Biotechnology: Institutions and Markets in Industrial Innovation. London.
Perlman, D. (1975). Influence of penicillin fermentation technology to processes for production of other antibiotics. Process Biochemistry, 10(9):23.
Peter, V. (2001). Einführung in die biotechnologie. In Peter, V., editor, Institutionen im Innovationsprozess: Eine Analyse anhand der biotechnologischen Innovationssysteme in Deutschland und Japan, pages 65–88.
Porter, M. E. (1980). Competitive Strategy. Techniques for Analyzing Industries and Competitors. New York: Free Press.
Prantl, S. (2003). Bankruptcy and voluntary liquidation: Evidence for new firms in East and West Germany after unification. Technical Report 03-72, ZEW Discussion Paper, Mannheim.
Rogerson, W. (1983). Reputation and product quality. Bell Journal of Economics, 14:508–516.
Schumpeter, J. (1911). Theorie der wirtschaftlichen Entwicklung. Eine Untersuchung über Unternehmergewinn, Kapital, Kredit, Zins und den Konjunkturzyklus. München.
Schumpeter, J. A. (1934). The Theory of Economic Development. Cambridge MA: Harvard University Press.
Schumpeter, J. A. (1943). Capitalism, socialism and democracy. London: George Allen & Unwin (Publishers) Ltd.
Shapiro, C. (1983). Premiums for high quality products as returns to reputations. The Quarterly Journal of Economics, 98(4):659–679.
Spence, A. (1984). Cost reduction, competition, and industry performance. Econometrica, 52:101–121.
Stahl, K. (1991). Das Mannheimer Unternehmenspanel: Konzept und Entwicklung. Mitteilungen aus der Arbeitsmarkt-und Berufsforschung, 28:735–738.
Wink, M. (2004). Molekulare Biotechnologie, chapter Die Zelle ist die Grundeinheit des Lebens, pages 3–29. Weinheim.
Wörner, S., Reiss, T., Menrad, M., and Menrad, K. (2000). European biotechnology innovation systems: Case study Germany. Bericht für die Europäische Kommission (SOE1-CT98-1117). Fraunhofer-Institut für Systemtechnik und Innovationsforschung, Karlsruhe, 118.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fier, A., Heneric, O. (2009). Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry. In: Keilbach, M., Tamvada, J.P., Audretsch, D.B. (eds) Sustaining Entrepreneurship and Economic Growth. International Studies in Entrepreneurship, vol 19. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78695-7_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-78695-7_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78694-0
Online ISBN: 978-0-387-78695-7
eBook Packages: Business and EconomicsBusiness and Management (R0)